Armstrong Fleming & Moore Inc Takes Position in Merck & Co., Inc. (NYSE:MRK)
Armstrong Fleming & Moore Inc acquired a new stake in Merck & Co., Inc. (NYSE:MRK – Free Report) in the second quarter, HoldingsChannel.com reports. The firm acquired 8,443 shares of the company’s stock, valued at approximately $974,000. Merck & Co., Inc. accounts for 0.9% of Armstrong Fleming & Moore Inc’s investment portfolio, making the stock […]